Ignite Creation Date:
2025-12-24 @ 11:44 PM
Ignite Modification Date:
2026-01-03 @ 1:53 PM
Study NCT ID:
NCT02023151
Status:
COMPLETED
Last Update Posted:
2017-12-11
First Post:
2013-12-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Predicting the Clinical Response to Omalizumab With Anti-Immunoglobulin E (IgE) Ab Response or Syk Expression in Basophils
Sponsor:
Johns Hopkins University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-02
Start Date Type:
None
Primary Completion Date:
2016-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-08
Completion Date Type:
ACTUAL
First Submit Date:
2013-12-17
First Submit QC Date:
None
Study First Post Date:
2013-12-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-07-31
Results First Submit QC Date:
None
Results First Post Date:
2017-12-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-11-09
Last Update Post Date:
2017-12-11
Last Update Post Date Type:
ACTUAL